FOXO4-DRI Peptide – 10mg

What Is It?

FOXO4-DRI is a synthetic D-retro-inverso peptide developed to selectively target senescent (“zombie”) cells—aged cells that no longer divide normally but remain metabolically active and release inflammatory signaling molecules known as the senescence-associated secretory phenotype (SASP).

Unlike compounds that broadly stimulate regeneration, FOXO4-DRI is designed to remove dysfunctional senescent cells by disrupting the interaction between the FOXO4 protein and p53, allowing senescent cells to undergo programmed cell death (apoptosis) while largely sparing healthy cells.

FOXO4-DRI has become one of the most widely studied experimental senolytic peptides in longevity research.

What Does It Do?

FOXO4-DRI is being investigated for its ability to:

• Selectively eliminate senescent cells

• Reduce chronic inflammatory SASP signaling

• Support healthier tissue regeneration

• Improve cellular resilience during aging

• Promote healthier tissue microenvironments

• Support healthy function of aging organs

Because senescent cells accumulate with age, they are thought to contribute to declining tissue function, chronic inflammation, fibrosis, and impaired regeneration. Removing these cells may allow healthier neighboring cells to function more efficiently.

How Does It Function in the Body?

1. Disrupts FOXO4–p53 Binding

In senescent cells, FOXO4 binds to the tumor suppressor protein p53, keeping it within the nucleus and preventing apoptosis.

FOXO4-DRI competitively disrupts this interaction.

This allows p53 to relocate and activate the apoptotic machinery specifically within senescent cells.

2. Selective Senescent Cell Clearance

Rather than damaging healthy tissue, FOXO4-DRI preferentially induces apoptosis in cells expressing senescence markers such as:

• p16INK4a

• p21

• Senescence-associated β-galactosidase

Healthy proliferating cells are far less affected in experimental models.

3. Reduces SASP (Senescence-Associated Secretory Phenotype)

Senescent cells produce inflammatory cytokines and enzymes that may contribute to:

• Chronic inflammation

• Fibrosis

• Tissue degeneration

• Impaired regeneration

By reducing the burden of senescent cells, FOXO4-DRI may decrease this inflammatory signaling environment.

4. Supports Tissue Homeostasis

Following senescent cell clearance, preclinical studies suggest tissues may demonstrate:

• Improved regenerative capacity

• Better structural organization

• Enhanced cellular function

• Improved tissue homeostasis

These observations have been reported across multiple aging and injury models.

What Do Studies Show?

Research to date is primarily preclinical, with a growing number of experimental animal studies.

Published studies have reported that FOXO4-DRI:

• Selectively removes senescent cells while largely sparing healthy cells.

• Restores tissue function in mouse models of accelerated aging and chemotherapy-induced tissue damage.

• Improves vascular function and reduces endothelial senescence in aging models by disrupting the FOXO4–p53 interaction.

• Reduces inflammatory signaling and improves tissue quality in experimental cartilage and chondrocyte models.

• Demonstrates potential benefits in fibrosis, wound repair, reproductive aging, and other age-related conditions in animal models.

Important: At present, FOXO4-DRI remains an investigational research peptide. Large-scale human clinical trials evaluating safety and efficacy are still limited.

Overall Benefits

Based on current experimental research, FOXO4-DRI is commonly investigated for its potential to support:

• Senescent cell clearance

• Healthy aging research

• Reduced chronic inflammatory signaling

• Improved tissue regeneration

• Cellular resilience

• Vascular health

• Organ function during aging

• Tissue remodeling and repair

Scientific Positioning

FOXO4-DRI is a next-generation senolytic peptide engineered to selectively eliminate dysfunctional senescent cells by disrupting the FOXO4–p53 interaction. Rather than stimulating growth directly, it is being investigated for its ability to restore healthier tissue environments through targeted removal of aged cells, potentially supporting tissue regeneration, reduced inflammatory signaling, and improved cellular homeostasis.